StonvexLoading…
StonvexStonvexStonvexCore line items from FHB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $220.35M | $880.79M | $654.93M | $428.54M |
Operating Income | $87.46M | $354.24M | $261.19M | $165.04M |
Net Income | $67.78M | $276.27M | $206.34M | $132.50M |
EPS (Diluted) | $0.55 | $2.20 | $1.64 | $1.05 |
Total Assets | $24.26B | $23.96B | $24.10B | $23.84B |
Total Liabilities | $21.50B | $21.19B | $21.36B | $21.14B |
Cash & Equivalents | $1.72B | $1.48B | $1.86B | $1.40B |
Free Cash Flow OCF − CapEx | $155.42M | $303.29M | $203.30M | $153.78M |
Shares Outstanding | 121.65M | 122.69M | 123.72M | 124.68M |